Concord Biotech IPO: How to check allotment status

Concord Biotech’s initial public offer (IPO), comprising an offer for sale (OFS) worth Rs 1,551 crore, concluded last week with an overall subscription of almost 25 times the equity on offer.  The IPO of Concord Biotech was sold in the range of Rs 705-741 apiece. The basis of the allotment of shares under the Concord Biotech Limited IPO is likely to be finalised on August 11. Successful bidders will get Concord Biotech shares credited into their demat accounts on August 17 whereas other participants will have refunds initiated on August 14. Concord Biotech shares will likely be listed on stock exchanges BSE and NSE on August 18.

Concord Biotech Limited IPO: Here's a step-by-step guide on how to check the allotment status

Those who participated in the Concord Biotech Limited IPO can check the status of their application online in two ways: through the BSE website and through the website of the registrar.

How to check the allotment status through the BSE website

Step 1: A bidder is required to visit the official website of the BSE to check the status of the IPO application online. Login at the direct BSE link — bseindia.com/investors/appli_check.aspx
Step 2: Select the option of 'Equity' under 'Issue Type'
Step 3: Select 'Issue Name'. Either enter your application number in the box or provide your PAN detail to proceed further.
Step 4: Click on 'I'm not a robot' and then submit.

The status of your Concord Biotech Limited IPO application status will appear on the screen.

How to check the allotment status through the registrar's website

A bidder may log in at direct Link Intime web link — linkintime.co.in/MIPO/Ipoallotment.html and follow through to check the status of the IPO application online.

Concord Biotech Limited IPO allotment status check on Link Intime

Step 1: Log in at the direct Link Intime web link — linkintime.co.in/MIPO/Ipoallotment.html;
Step 2: Select- Concord Biotech Limited IPO
Step 3: Bidder then has to enter PAN details
Step 4: Click on the 'Search' option.

The status of Concord Biotech Limited IPO application status will appear on the screen.

About Concord Biotech Limited

Concord Biotech Limited is an R&D-driven biopharma company. The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.

Catch the latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.